Identification of the Candida albicans Cap1p Regulon
暂无分享,去创建一个
G. Boucher | Sadri Znaidi | K. Barker | M. Raymond | A. Alarco | Teresa T Liu | S. Weber | P. Rogers
[1] G. Bellí,et al. Redox control and oxidative stress in yeast cells. , 2008, Biochimica et biophysica acta.
[2] Yuan-Ying Jiang,et al. RTA2, a novel gene involved in azole resistance in Candida albicans. , 2008, Biochemical and biophysical research communications.
[3] J. Morschhäuser,et al. Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains , 2008, Molecular microbiology.
[4] R. Homayouni,et al. A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.
[5] S. K. Balakrishnan,et al. The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model , 2008, Oncogene.
[6] F. Robert,et al. Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance , 2008, Eukaryotic Cell.
[7] R. Homayouni,et al. The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.
[8] Sadri Znaidi,et al. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans , 2007, Molecular microbiology.
[9] R. Homayouni,et al. Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.
[10] D. Diogo,et al. Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates , 2007, Eukaryotic Cell.
[11] R. H. Gross,et al. A novel ensemble learning method for de novo computational identification of DNA binding sites , 2007, BMC Bioinformatics.
[12] M. Molin,et al. Ionizing radiation induces a Yap1-dependent peroxide stress response in yeast. , 2007, Free radical biology & medicine.
[13] Peter J. Park,et al. Normalization and experimental design for ChIP-chip data , 2007, BMC Bioinformatics.
[14] Hugo Y. K. Lam,et al. Tilescope: online analysis pipeline for high-density tiling microarray data , 2007, Genome Biology.
[15] Robert H. Gross,et al. SCOPE: a web server for practical de novo motif discovery , 2007, Nucleic Acids Res..
[16] S. Engelmann,et al. Proteomic analysis of the oxidative stress response in Candida albicans , 2007, Proteomics.
[17] D. Sanglard,et al. Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. , 2006, Microbiology.
[18] C. Kumamoto,et al. Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site , 2006, Eukaryotic Cell.
[19] Clifford A. Meyer,et al. Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.
[20] B. Turcotte,et al. A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins , 2006, Microbiology and Molecular Biology Reviews.
[21] Michael R. Seringhaus,et al. TOS9 Regulates White-Opaque Switching in Candidaalbicans , 2006, Eukaryotic Cell.
[22] Lin Tang,et al. Inferring direct regulatory targets from expression and genome location analyses: a comparison of transcription factor deletion and overexpression , 2006, BMC Genomics.
[23] Charles Boone,et al. Identifying transcription factor functions and targets by phenotypic activation , 2006, Proceedings of the National Academy of Sciences.
[24] J. Morschhäuser,et al. Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate , 2006, Antimicrobial Agents and Chemotherapy.
[25] L. A. Stargell,et al. TFIIA Plays a Role in the Response to Oxidative Stress , 2006, Eukaryotic Cell.
[26] M. Raymond,et al. PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.
[27] J. Latgé,et al. Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus , 2006, Nature Reviews Microbiology.
[28] J. Berman,et al. A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans , 2006, Genetics.
[29] K. Ying,et al. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. , 2006, Free radical biology & medicine.
[30] T. Hughes,et al. Mapping pathways and phenotypes by systematic gene overexpression. , 2006, Molecular cell.
[31] Brice Enjalbert,et al. Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. , 2005, Molecular biology of the cell.
[32] C. Bustamante. Treatment of Candida infection: a view from the trenches! , 2005, Current opinion in infectious diseases.
[33] T. C. White,et al. Drug-Induced Regulation of the MDR1 Promoter in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.
[34] R. Akins. An update on antifungal targets and mechanisms of resistance in Candida albicans. , 2005, Medical mycology.
[35] B. Akache,et al. Candida albicans Zinc Cluster Protein Upc2p Confers Resistance to Antifungal Drugs and Is an Activator of Ergosterol Biosynthetic Genes , 2005, Antimicrobial Agents and Chemotherapy.
[36] F. Klis,et al. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood , 2005, Molecular microbiology.
[37] F. Devaux,et al. Early Expression of Yeast Genes Affected by Chemical Stress , 2005, Molecular and Cellular Biology.
[38] D. Sanglard,et al. TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.
[39] Yoshiharu Inoue,et al. Activity of the Yap1 Transcription Factor in Saccharomyces cerevisiae Is Modulated by Methylglyoxal, a Metabolite Derived from Glycolysis , 2004, Molecular and Cellular Biology.
[40] P. Jolicoeur,et al. Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection , 2004, Clinical Microbiology Reviews.
[41] G. Goldman,et al. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. , 2004, Diagnostic microbiology and infectious disease.
[42] Alix T. Coste,et al. Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters , 2004, Antimicrobial Agents and Chemotherapy.
[43] J. Lieb,et al. ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. , 2004, Genomics.
[44] J. Sobel,et al. Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] D. Pittet,et al. Management of candidiasis Management of Candida species infections in critically ill patients , 2003 .
[46] W. Scott Moye-Rowley,et al. Regulation of the Transcriptional Response to Oxidative Stress in Fungi: Similarities and Differences , 2003, Eukaryotic Cell.
[47] C. Nombela,et al. The Hog1 Mitogen-Activated Protein Kinase Is Essential in the Oxidative Stress Response and Chlamydospore Formation in Candidaalbicans , 2003, Eukaryotic Cell.
[48] M. Waters,et al. A survey of EPA/OPP and open literature on selected pesticide chemicals. III. Mutagenicity and carcinogenicity of benomyl and carbendazim. , 2002, Mutation research.
[49] J. Morschhäuser. The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.
[50] S. Kelly,et al. Molecular basis of resistance to azole antifungals. , 2002, Trends in molecular medicine.
[51] D. Sanglard,et al. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. , 2002, The Lancet. Infectious diseases.
[52] Yoshiharu Inoue,et al. Regulation of the Yeast Yap1p Nuclear Export Signal Is Mediated by Redox Signal-Induced Reversible Disulfide Bond Formation , 2001, Molecular and Cellular Biology.
[53] M. Raymond,et al. Multiple Yap1p-binding Sites Mediate Induction of the Yeast Major Facilitator FLR1 Gene in Response to Drugs, Oxidants, and Alkylating Agents* , 2001, The Journal of Biological Chemistry.
[54] D. Sanglard,et al. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.
[55] J. Morschhäuser,et al. Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.
[56] D. Sanglard,et al. Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p , 2000, Molecular microbiology.
[57] P. Sudbery,et al. The MET3 promoter: a new tool for Candida albicans molecular genetics , 1999, Molecular microbiology.
[58] M. Waters,et al. A survey of EPA/OPP and open literature on selected pesticide chemicals. II. Mutagenicity and carcinogenicity of selected chloroacetanilides and related compounds. , 1999, Mutation research.
[59] M. Raymond,et al. The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response inCandida albicans , 1999, Journal of bacteriology.
[60] L H Lee,et al. Crm1p mediates regulated nuclear export of a yeast AP‐1‐like transcription factor , 1998, The EMBO journal.
[61] T. Toda,et al. Crm1 (XpoI) dependent nuclear export of the budding yeast transcription factor yAP‐1 is sensitive to oxidative stress , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[62] M. Raymond,et al. AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.
[63] N Jones,et al. Regulation of yAP‐1 nuclear localization in response to oxidative stress , 1997, The EMBO journal.
[64] J. Wemmie,et al. The Saccharomyces cerevisiae AP-1 Protein Discriminates between Oxidative Stress Elicited by the Oxidants H2O2 and Diamide* , 1997, The Journal of Biological Chemistry.
[65] A. Futcher,et al. Use of polymerase chain reaction epitope tagging for protein tagging in Saccharomyces cerevisiae , 1995, Yeast.
[66] D. Irwin,et al. Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.
[67] Ellson Y. Chen,et al. Overview of manual and automated DNA sequencing by the dideoxy chain termination method , 1991 .
[68] T. A. Brown,et al. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. , 1990, Nucleic acids research.
[69] S. Miller,et al. Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants , 1987, Molecular and cellular biology.
[70] K. Ying,et al. Cap1p plays regulation roles in redox, energy metabolism and substance transport: an investigation on Candida albicans under normal culture condition. , 2007, Frontiers in bioscience : a journal and virtual library.
[71] D. Pittet,et al. Management of Candida species infections in critically ill patients. , 2003, The Lancet. Infectious diseases.
[72] F. Sherman. Getting started with yeast. , 1991, Methods in enzymology.
[73] Gerald R. Fink,et al. Methods in Yeast Genetics: A Laboratory Course Manual , 1987 .